Molecular Rx, Inc.

Calculating rank

USPTO Granted Patents = 6

Forward Citations = 53

Loading Chart...

4 inventors (with patents filed for the assignee):

Ellis L Kline (5 out of 12 patents)

Walter W McAlhaney (2 out of 2 patents)

Daniel H Zimmerman (1 out of 18 patents)

4. John P McMichael (1 out of 45 patents)

6 patents: Sort by Forward Citations

1. 5846532 - Method and composition for the treatment of disorders involving (1998-12-08),

2. 5804188 - Method and composition for treatment of disorders involving (1998-09-08),

3. 5736133 - Method and composition for the treatment of a individual infected with (1998-04-07),

4. 5645997 - Assay and treatment for demyelinating diseases such as multiple (1997-07-08),

5. 5558863 - Method for treatment of herpes virus infections (1996-09-24),

6. 4966753 - Immunotherapeutic methods and compositions employing antigens (1990-10-30),

Company Overview

Molecular Rx, Inc. is a leading biotechnology company focused on developing innovative therapeutics for a variety of diseases. With a strong emphasis on research and development, Molecular Rx is dedicated to advancing the field of molecular medicine through cutting-edge technologies and strategic partnerships. The company's mission is to transform patient care by delivering targeted treatments that address unmet medical needs and improve outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#80 in Nashville, TN

#477 in Tennessee

#45,030 in US

Nashville, TN, United States of America

Molecular Rx, Inc.

Forward Citations = 53

4 inventors:

Ellis L Kline (5 out of 12 patents)

Walter W McAlhaney (2 out of 2 patents)

Daniel H Zimmerman (1 out of 18 patents)

4. John P McMichael (1 out of 45 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Molecular Rx, Inc.. Retrieved from https://idiyas.com/company/molecular-rx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]